Napa Therapeutics

Taking a very important first step in Juvenescence’s model to create collaborations between basic scientists and drug developers.

Napa Therapeutics is a Joint Venture between Juvenescence and The Buck Institute for Research on Aging.

Napa Therapeutics is a discovery-stage company focused on NAD+ metabolism. There is ample evidence that NAD+ depletion is a key feature of aging. Napa’s core IP will surround a novel target within NAD+ metabolism to increase levels of NAD+ within the tissue.